LY4065967
DrugAdministered orally
NCT Number: NCT07641517
The main purpose of this study is to test the safety and efficacy of study drug for the treatment of knee pain due to osteoarthritis (OA). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292), which is a protocol to accelerate the development of new treatments for chronic pain.
Trial opening soon.
Get Notified40 year and older
All sexes
Interventional
Phase 2
Ponce Medical School Foundation Inc., Ponce, Puerto Rico
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Administered orally
Administered orally
Time frame: Baseline, Week 8
Time frame: Baseline, week 8
Time frame: Baseline, Week 8
Time frame: Baseline, Week 8
Time frame: Baseline, Week 8
Time frame: Baseline, Week 8
Time frame: Baseline, Week 8
Contact information is provided by the study sponsor or research team.
Physicians interested in becoming principal investigators please contact
CONTACT
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
CONTACT
Eli Lilly and Company
Industry
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY4065967 for the Treatment of Osteoarthritis
Acronym: OA07
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05761015
Arthritis, Chronic Pain
Clermont-Ferrand, France
View Trial DetailsNCT04427709
Arthritis, Chronic Pain
Winston-Salem, North Carolina, United States
View Trial DetailsNCT06477965
Arthritis, Chronic Pain
Cary, North Carolina, United States
View Trial DetailsNCT03774121
Arthritis, Behavior
Esbjerg, Region Syddanmark, Denmark
View Trial Details